Auer L M, Oberbauer R W, Schalk H V
Stroke. 1983 Mar-Apr;14(2):210-3. doi: 10.1161/01.str.14.2.210.
In previous experimental work, the Ca-antagonist Nimodipine had shown a predominantly cerebroarterial dilatory effect. In the present double-blind study of 16 patients, pial arterial and venous reaction was investigated during EC-IC bypass surgery, infusing 1 microgram kg-1min-1 of Nimodipine intravenously. In pial arteries with resting diameters between 25 and 70 micrometers, a significant 18% dilatation was observed. Results are considered promising for future trials in the treatment and prevention of cerebral ischemia caused by vasoconstriction or vasospasm, especially vasospasm following subarachnoid hemorrhage.
在先前的实验工作中,钙拮抗剂尼莫地平已显示出主要的脑动脉扩张作用。在本次针对16名患者的双盲研究中,在进行颅外-颅内血管搭桥手术期间,以每分钟每千克体重1微克的剂量静脉输注尼莫地平,研究软脑膜动脉和静脉的反应。在静息直径为25至70微米的软脑膜动脉中,观察到显著的18%的扩张。这些结果对于未来治疗和预防由血管收缩或血管痉挛(尤其是蛛网膜下腔出血后的血管痉挛)引起的脑缺血的试验而言是有前景的。